<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.todayinscience.com/article/906632426-author-gene-therapy-pioneer-and-film-producer-patrick-girondi-at-oxford-exchange-author-fair-in-tampa-on-april-23-26</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-19T10:22:58+00:00</news:publication_date>
        <news:title>Author, Gene Therapy Pioneer, and Film Producer Patrick Girondi at Oxford Exchange Author Fair in Tampa on April 23  &#39;26</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835743-patrick-bestseller-poster-1650x2550.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906732361-cregis-shines-at-paris-blockchain-week-2026-accelerating-european-expansion</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-19T09:45:18+00:00</news:publication_date>
        <news:title>Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5bebd304-3269-4385-9874-50701ff2353a/medium/cover-image.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906711088-challenge-accepted-schneider-electric-helps-industry-turn-toughest-problems-into-competitive-advantage</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-19T07:00:00+00:00</news:publication_date>
        <news:title>Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f9f1757e-4ed3-4fe7-939b-35cd2b1f43e1/medium/schneider-electric.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906516518-applications-open-for-the-m-gazi-ya-argil-young-neurosurgeon-award</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T16:32:57+00:00</news:publication_date>
        <news:title>Applications Open for the &#39;M. Gazi Yaşargil Young Neurosurgeon Award&#39;</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835627-m-gazi-ya-argil-young-neurosur-1080x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906674833-direct-meds-glp-1-2026-claims-examined-pricing-verified-what-consumers-should-confirm-before-buying</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-19T03:39:34+00:00</news:publication_date>
        <news:title>Direct Meds GLP-1 2026: Claims Examined, Pricing Verified &amp; What Consumers Should Confirm Before Buying</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/065e49c6-04a6-4223-a1ee-caea644c6a7f/medium/direct-meds.PNG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906674828-strovemont-capital-claims-evaluated-is-strovemont-capital-trading-platform-legit-hidden-features-trust-facts-real-user-results</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-19T03:10:24+00:00</news:publication_date>
        <news:title>Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts &amp; Real User Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6c80b7b0-a3e5-46d9-a0a2-28f7c0c723bc/medium/strovemont-capital.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906659883-bramridge-trust-unveiled-should-you-join-bramridge-trust-features-performance-fees-real-user-insights</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-19T02:30:20+00:00</news:publication_date>
        <news:title>Bramridge Trust Unveiled:  Should You Join Bramridge Trust? Features, Performance, Fees &amp; Real User Insights!</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/298d2649-26e8-49ac-ab07-531c079947cf/medium/bramridge-trust.PNG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906622428-crypto-news-alphapepe-ai-dex-demo-over-1000-users-whilst-xrp-price-prediction-targets-5-00-following-official-sec-commodity-status</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T22:45:00+00:00</news:publication_date>
        <news:title>Crypto News: AlphaPepe AI DEX Demo Over 1000 Users Whilst XRP Price Prediction Targets $5.00 Following Official SEC Commodity Status</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bb8173de-d338-4af5-9802-2bcdb498429b/medium/alphapepe.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906577634-pliant-therapeutics-announces-presentation-of-updated-data-from-the-phase-1-trial-of-pln-101095-in-patients-with-ici-refractory-solid-tumors-at-the</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T17:31:00+00:00</news:publication_date>
        <news:title>Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095  in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e31d4c37-738e-4662-861d-675c8c564317/medium/figure-1.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906577667-ring-a-ding-launches-openclaw-skill-for-ai-agent-phone-calls</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T17:18:25+00:00</news:publication_date>
        <news:title>Ring-a-Ding Launches OpenClaw Skill for AI Agent Phone Calls</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/d39b62af-4928-42e0-a75f-20e6a819ac8a/screenshot-2026-04-15-at-14-00-39.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906577555-theriva-biologics-anuncia-la-pr-xima-presentaci-n-de-datos-adicionales-del-ensayo-cl-nico-virage-de-fase-2b-del-vcn-01-para-el-c-ncer-de-p-ncreas</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T17:17:08+00:00</news:publication_date>
        <news:title>Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906552980-maps-welcomes-federal-action-to-advance-science-driven-psychedelic-research-and-policy</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T15:34:50+00:00</news:publication_date>
        <news:title>MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4f774750-4742-4818-be22-116e2b2085b1/small/maps-logo-2021-primary-horizontal-white-background-1200x486.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906525665-other-world-computing-owc-launches-macdrive-12-at-nab-2026-one-solution-for-complete-mac-disk-access-on-windows-including-native-encrypted-apfs</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T12:30:00+00:00</news:publication_date>
        <news:title>Other World Computing (OWC) Launches MacDrive 12 at NAB 2026 – One Solution for Complete Mac Disk Access on Windows - Including Native Encrypted APFS Support</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/543d94b6-063b-4931-b524-f7b75a9d230c/medium/owc-macdrive-12-application-window-screenshot.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906525713-other-world-computing-launches-owc-express-4m2-ultra-at-nab-2026-thunderbolt-5-four-slot-nvme-m-2-ssd-enclosure</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T12:30:00+00:00</news:publication_date>
        <news:title>Other World Computing Launches OWC Express 4M2 Ultra at NAB 2026 – Thunderbolt 5 Four-Slot NVMe M.2 SSD Enclosure</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d50919d2-169d-4edd-8afc-6ca3693ad99d/medium/owc-4m2-ultra-front.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906526269-tradull-develops-structured-framework-to-improve-visibility-in-commodity-trade-processes</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T11:36:23+00:00</news:publication_date>
        <news:title>Tradull Develops Structured Framework to Improve Visibility in Commodity Trade Processes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e0fbd3ef-5565-4bc7-a9c9-d9d1acca96a6/medium/tradull.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906353045-kbl-advisors-details-integrated-advisory-model-for-skincare-development</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T22:04:49+00:00</news:publication_date>
        <news:title>KBL Advisors Details Integrated Advisory Model for Skincare Development</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835536-kbl-advisors-image-1200x1200.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906352623-kbl-advisors-highlights-vision-and-process-for-scalable-product-development</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T22:03:36+00:00</news:publication_date>
        <news:title>KBL Advisors Highlights Vision and Process for Scalable Product Development</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835535-kbl-advisors-photo-1200x1200.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906354160-kbl-advisors-supports-structured-development-in-home-fragrance-fabric-care-and-home-care-markets</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T22:02:53+00:00</news:publication_date>
        <news:title>KBL Advisors Supports Structured Development in Home Fragrance, Fabric Care and Home Care Markets</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835535-kbl-advisors-photo-1200x1200.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906501406-press-release-escmid-sanofi-s-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T10:00:00+00:00</news:publication_date>
        <news:title>Press Release: ESCMID: Sanofi&#39;s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906501531-communiqu-de-presse-escmid-le-nuvaxovid-vaccin-contre-la-covid-19-de-sanofi-a-montr-une-meilleure-tol-rance-que-le-mnexspike-dans-une-tude</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T10:00:00+00:00</news:publication_date>
        <news:title>Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906351098-boston-musician-travels-cross-country-for-a-complex-brain-tumor-surgery-and-returns-to-the-stage-nine-weeks-later</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T21:32:12+00:00</news:publication_date>
        <news:title>Boston Musician Travels Cross-Country for a Complex Brain Tumor Surgery — And Returns to the Stage Nine Weeks Later</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24723552-dr-aaron-gadol-1064x1234.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/863608855-mississauga-clinic-offers-access-to-breakthrough-deep-tms-therapy-for-depression</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:22:23+00:00</news:publication_date>
        <news:title>Mississauga Clinic Offers Access to Breakthrough Deep TMS Therapy for Depression</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24060438-nextwave-logo-912x642.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906155869-women-in-stem-are-paying-it-forward-as-techbridge-girls-sustainers</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:02:37+00:00</news:publication_date>
        <news:title>Women in STEM Are Paying It Forward as Techbridge Girls Sustainers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834629-tbg-sustainer-1080x1350.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906476329-crypto-news-alphapepe-announces-880k-raised-while-ethereum-price-prediction-targets-4-000-on-heavy-whale-accumulation</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T07:00:00+00:00</news:publication_date>
        <news:title>Crypto News: AlphaPepe Announces $880k Raised While Ethereum Price Prediction Targets $4,000 on Heavy Whale Accumulation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/64727b55-920f-41c6-8367-978501174859/medium/alphapepe.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906451168-argenx-brings-neuromuscular-leadership-to-aan-2026-with-new-data-supporting-broader-vyvgart-use-across-mg-and-cidp</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T05:00:00+00:00</news:publication_date>
        <news:title>argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906165975-genvor-announces-strategic-memorandum-of-understanding-with-canlab-international-tm-to-advance-peptide-pipeline</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T16:00:11+00:00</news:publication_date>
        <news:title>Genvor Announces Strategic Memorandum of Understanding with Canlab International(TM) to Advance Peptide Pipeline</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834706-gnvr-primary-pic-4-2048x1024.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906451027-b2gold-reports-fire-related-incident-to-the-crushing-circuit-at-the-goose-mine</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T03:59:18+00:00</news:publication_date>
        <news:title>B2Gold Reports Fire-Related Incident to the Crushing Circuit at the Goose Mine</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d8bdd545-6088-4788-bd5a-44a0dba04191/small/3906-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906321129-small-satellites-big-impact-mc3-network-inspires-space-innovation-at-naval-postgraduate-school</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T15:56:56+00:00</news:publication_date>
        <news:title>Small Satellites, Big Impact — MC3 Network Inspires Space Innovation at Naval Postgraduate School</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835272-mc3-lead-2554x1704.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906311636-an-important-nikola-tesla-signed-holograph-page-from-a-scientific-article-he-wrote-in-1907-will-be-auctioned-april-30th</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T14:53:14+00:00</news:publication_date>
        <news:title>An important Nikola Tesla signed holograph page from a scientific article he wrote in 1907 will be auctioned April 30th</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835229-nt-0426-1024x1024.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906400487-redcloud-holdings-plc-receives-notice-regarding-minimum-bid-price-requirement</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-18T00:15:00+00:00</news:publication_date>
        <news:title>RedCloud Holdings Plc Receives Notice Regarding Minimum Bid Price Requirement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5c1cfb28-9945-43bb-a5bc-7789676cae2f/small/2023-redcloud-product-logos-13-e1691517467929-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906400070-grupo-aeroportuario-del-pacifico-announces-filing-of-2025-annual-report-and-form-20-f</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T22:57:23+00:00</news:publication_date>
        <news:title>Grupo Aeroportuario del Pacifico Announces Filing of 2025 Annual Report and Form 20-F</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a8b922ac-5cd6-4342-afd5-c5c2aea7213c/small/gap-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906400275-crypto-news-alphapepe-announces-870k-raised-amid-dogecoin-price-prediction-targeting-0-47-following-x-money-beta-launch</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T22:30:00+00:00</news:publication_date>
        <news:title>Crypto News: AlphaPepe Announces $870k Raised Amid Dogecoin Price Prediction Targeting $0.47 Following X Money Beta Launch</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/01407950-d491-485a-8f91-08f42dedec11/medium/alphapepe.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906378380-fyresite-reaches-new-heights-with-shopify-premier-partner-promotion</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T21:58:00+00:00</news:publication_date>
        <news:title>Fyresite Reaches New Heights With Shopify Premier Partner Promotion</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3232398/jason-sean.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906378249-rocket-doctor-amends-45-degree-agreement</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T21:18:34+00:00</news:publication_date>
        <news:title>Rocket Doctor Amends 45 Degree Agreement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/648c6dd6-c4c0-4ceb-9a78-26fecd4678a7/small/rocket-doctor-logo-250821-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906376671-iovance-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T21:15:00+00:00</news:publication_date>
        <news:title>Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906378336-boundless-bio-presents-preclinical-breast-cancer-data-from-its-oral-kinesin-degrader-program-at-2026-aacr-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:49:47+00:00</news:publication_date>
        <news:title>Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3b8ff619-e7af-4c58-a7f2-de0c4019068d/small/boundlessbiologo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906378314-rpx-gold-announces-upsize-of-previously-announced-best-efforts-life-offering-and-private-placement-to-c-12-300-000</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:48:12+00:00</news:publication_date>
        <news:title>RPX Gold Announces Upsize of Previously Announced “Best Efforts” LIFE Offering and Private Placement to C$12,300,000</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Yjg5OGRlNTQtMjRmNy00NDgxLWJjMTEtYzcxMDdhMTFiMTAwLTUwMDE1OTk3MS0yMDI2LTA0LTE3LWVu/tiny/RPX-Gold-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906376058-celularity-announces-receipt-of-nasdaq-notice-regarding-late-form-10-k-filing</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:35:00+00:00</news:publication_date>
        <news:title>Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ODBmYzBlZTctZGRjMC00YzIzLWEyYTEtODVjOGVkNjJlM2M4LTEyMTY1NjItMjAyNi0wNC0xNy1lbg==/tiny/Celularity-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906375425-tree-island-steel-provides-update-on-annual-general-meeting-of-shareholders</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:30:00+00:00</news:publication_date>
        <news:title>Tree Island Steel Provides Update on Annual General Meeting of Shareholders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/69ae1989-1003-488d-afdd-22062f0fdf84/small/treeisland-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906376026-zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:15:00+00:00</news:publication_date>
        <news:title>Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906377393-bgin-blockchain-limited-schedules-the-fiscal-year-2025-earnings-and-conference-call-on-april-24-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:15:00+00:00</news:publication_date>
        <news:title>BGIN BLOCKCHAIN LIMITED Schedules the Fiscal Year 2025 Earnings and Conference Call on April 24, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZGIzMjlmYjItNmZjNy00YzI0LWJkZjYtM2Q4YTg3OWRkMWMwLTEzMDQ3MDEtMjAyNi0wNC0xNy1lbg==/tiny/BGIN-Blockchain-Limited.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906378008-ttec-schedules-first-quarter-2026-earnings-release-and-webcast-of-investor-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:10:00+00:00</news:publication_date>
        <news:title>TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8488146d-993c-40c8-8d4c-b993aa023cb2/small/screenshot-2025-10-17-132937-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906375383-alx-oncology-reports-inducement-grant-as-permitted-by-the-nasdaq-listing-rules</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:05:00+00:00</news:publication_date>
        <news:title>ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906375426-theriva-biologics-announces-upcoming-presentation-of-additional-data-from-the-virage-phase-2b-clinical-trial-of-vcn-01-in-metastatic-pancreatic</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:05:00+00:00</news:publication_date>
        <news:title>Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906375629-4dmt-announces-new-employment-inducement-grants</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:05:00+00:00</news:publication_date>
        <news:title>4DMT Announces New Employment Inducement Grants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906375662-camp4-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:05:00+00:00</news:publication_date>
        <news:title>CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906376293-sealsq-announces-agenda-of-its-2026-annual-general-meeting-of-shareholders</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:05:00+00:00</news:publication_date>
        <news:title>SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4071513d-3f7c-4a38-a055-8da38cfb60df/small/seal-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906376371-oric-pharmaceuticals-presents-preclinical-data-to-support-the-potential-of-rinzimetostat-across-prostate-cancer-and-in-emerging-resistance-settings</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:05:00+00:00</news:publication_date>
        <news:title>ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906376697-pyxis-oncology-to-present-new-preclinical-data-showing-synergistic-anti-tumor-activity-in-a-hnscc-model-with-mamicvo-in-combination-with-anti-pd-1-at</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:05:00+00:00</news:publication_date>
        <news:title>Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906377182-revolution-medicines-announces-closing-of-concurrent-upsized-public-offerings-with-aggregate-gross-proceeds-of-approximately-2-2-billion-including</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:02:00+00:00</news:publication_date>
        <news:title>Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906375334-adagene-presents-two-posters-at-aacr-2026-with-new-data-highlighting-muzastotug-s-potential-as-a-backbone-combination-therapy-for-multiple-tumor-types</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:01:00+00:00</news:publication_date>
        <news:title>Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c377318b-edf7-42c0-8e7c-63a02bbe47b0/small/adagene-logo-gnw-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906375816-xilio-therapeutics-announces-new-preclinical-data-at-aacr-annual-meeting-for-xtx601-a-masked-t-cell-engager-targeting-cldn18-2</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:01:00+00:00</news:publication_date>
        <news:title>Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906376062-cardiff-oncology-presents-preclinical-data-on-its-plk1-inhibitor-onvansertib-in-combination-with-a-her2-targeted-adc-at-the-2026-aacr-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:01:00+00:00</news:publication_date>
        <news:title>Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906376104-olema-oncology-announces-preclinical-data-for-palazestrant-and-op-3136-at-the-2026-aacr-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T20:01:00+00:00</news:publication_date>
        <news:title>Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906376376-introspect-technology-adds-new-ate-on-bench-solution-for-lpddr6-ddr6-and-hbm-interfaces</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:35:00+00:00</news:publication_date>
        <news:title>Introspect Technology Adds New ATE-on-Bench Solution for LPDDR6, DDR6, and HBM Interfaces</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/19aadf5f-2b49-4538-85c2-e627dd7daa42/medium/introspect-technology-m5504-highspeed-digital-tester.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906351275-zentalis-pharmaceuticals-to-present-azenosertib-preclinical-data-in-triple-negative-breast-cancer-and-real-world-analysis-of-unmet-need-in-cyclin</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:15:00+00:00</news:publication_date>
        <news:title>Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906350057-evaxion-s-ai-immunology-platform-demonstrates-86-vaccine-target-precision-in-phase-2-personalized-cancer-vaccine-trial</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:10:00+00:00</news:publication_date>
        <news:title>Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906349949-prame-directed-cell-therapy-using-immatics-tcr-induces-deep-and-durable-remission-in-pediatric-patient-with-advanced-metastatic-nephroblastoma</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:00:00+00:00</news:publication_date>
        <news:title>PRAME-directed Cell Therapy Using Immatics’ TCR  Induces Deep and Durable Remission in Pediatric Patient  with Advanced Metastatic Nephroblastoma</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/1ef1cd0c-384c-4889-82c8-58bd42054fb8/small/immatics-final-logo-r-white-background-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906349959-asgard-therapeutics-to-present-preclinical-data-on-lead-asset-at-108-a-personalized-off-the-shelf-gene-therapy-at-aacr-annual-meeting-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:00:00+00:00</news:publication_date>
        <news:title>Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/5afbd1fa-9d4b-48d2-8f4f-d262d5a69053/small/asgard-tx-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906350035-new-data-demonstrates-the-unique-scalability-of-evaxion-s-ai-immunology-platform-in-glioblastoma</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:00:00+00:00</news:publication_date>
        <news:title>New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906350165-pheast-therapeutics-reports-initial-phase-1a-data-showing-early-clinical-activity-and-target-engagement-for-phst001-at-aacr-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:00:00+00:00</news:publication_date>
        <news:title>Pheast Therapeutics Reports Initial Phase 1a Data Showing Early Clinical Activity and Target Engagement for PHST001 at AACR 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f27ab630-f23c-44f6-aae6-6fae240628af/small/pheast-logo-full-color-gradient-high-res-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906350188-zymeworks-presents-new-preclinical-data-at-aacr-2026-highlighting-broad-antibody-drug-conjugate-programs-including-novel-ras-targeting-platform</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:00:00+00:00</news:publication_date>
        <news:title>Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906350191-biolojic-design-presents-new-preclinical-data-for-bd200-a-first-in-class-multibody-drug-conjugate-targeting-trop-2-and-nectin-4-at-the-american</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:00:00+00:00</news:publication_date>
        <news:title>Biolojic Design Presents New Preclinical Data for BD200, a First-in-Class Multibody-Drug Conjugate Targeting Trop-2 and Nectin-4 at the American Association of Cancer Research Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e7e1405-b691-484b-818b-1cb571d71d5c/small/biolojic-design-logo-vertical-color-resized-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906351284-mink-therapeutics-reports-phase-ii-data-on-immune-reprogramming-and-durable-survival-in-pd-1-refractory-gastroesophageal-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T19:00:00+00:00</news:publication_date>
        <news:title>MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906351536-jimstoppani-com-announces-summer-shred-challenge-with-25-000-grand-prize</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T18:40:00+00:00</news:publication_date>
        <news:title>JimStoppani.com Announces Summer Shred Challenge with $25,000 Grand Prize</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3232316/Screenshot-2026-04-17-at-9.07.35%E2%80%AFAM.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906350253-opticore-eye-group-unveils-new-contact-lens-program-in-riverside-ca-for-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T17:57:00+00:00</news:publication_date>
        <news:title>Opticore Eye Group Unveils New Contact Lens Program in Riverside, CA for 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3232295/OpticoreSquareLogo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906350485-verum-messenger-introduces-major-platform-update-expanding-privacy-connectivity-and-digital-ecosystem</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T17:41:00+00:00</news:publication_date>
        <news:title>Verum Messenger Introduces Major Platform Update Expanding Privacy, Connectivity, and Digital Ecosystem</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3232258/VM-earth.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906351240-studio-6-grows-extended-stay-footprint-with-35-new-locations-in-2026</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T17:37:16+00:00</news:publication_date>
        <news:title>Studio 6 Grows Extended Stay Footprint with 35+ New Locations in 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ebb26941-7346-4f3b-add1-9964ca91c726/small/screenshot-2026-01-08-161306-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906351097-rebalancing-agents-hympavzi-pfizer-qfitlia-sanofi-alhemo-novo-nordisk-gain-ground-in-hemophilia-as-physicians-navigate-access-barriers-and</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T17:20:06+00:00</news:publication_date>
        <news:title>Rebalancing Agents Hympavzi (Pfizer), Qfitlia (Sanofi), Alhemo (Novo Nordisk) Gain Ground in Hemophilia as Physicians Navigate Access Barriers and Expanding Treatment Complexity</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YjgxMGRkMDMtMDRjMC00ZTU5LTljMTUtODU4OTIyZTdlNzAxLTUwMDE1MTQyOC0yMDI2LTA0LTE3LWVu/tiny/Spherix-Global-Insights.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906351224-pacemakers-market-to-reach-7-5-billion-by-2030-driven-by-expanding-clinical-indications-and-aging-demographics</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T17:08:16+00:00</news:publication_date>
        <news:title>Pacemakers Market to Reach $7.5 Billion by 2030, Driven by Expanding Clinical Indications and Aging Demographics</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906351001-kaltura-to-showcase-agentic-revenue-engagement-platform-at-adobe-summit-2026-demonstrating-how-agentic-ai-avatars-and-content-intelligence-turn</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T17:00:19+00:00</news:publication_date>
        <news:title>Kaltura to Showcase Agentic Revenue Engagement Platform at Adobe Summit 2026, Demonstrating How Agentic AI Avatars and Content Intelligence Turn Static ABM Pages Into Real-Time Conversations </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/584e487b-dd12-4a20-a5b1-c42f4579d369/small/kaltura-logo-vertical-colorsun-blacktext-small.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906350059-hii-introduces-distributed-maritime-operations-framework-in-support-of-u-s-navy-s-hedge-strategy</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T16:30:00+00:00</news:publication_date>
        <news:title>HII Introduces Distributed Maritime Operations Framework in Support of U.S. Navy’s “Hedge Strategy”</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7f7fbc65-0a9a-40cd-adfa-1117a6cb7f59/medium/manned-unmanned-teaming-2026-sea-air-space.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906349982-azerion-group-publishes-its-2025-annual-report</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T16:24:26+00:00</news:publication_date>
        <news:title>Azerion Group publishes its 2025 Annual Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/d0141ea1-1040-441d-bc5f-128b5fdfb4db/small/stacked-full-colour-logo-black-1-1-1-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.todayinscience.com/article/906329349-china-international-consumer-products-expo-2026-underway-in-haikou-with-over-3-400-brands</loc>
      <news:news>
        <news:publication>
          <news:name>Today in Science</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-04-17T15:09:33+00:00</news:publication_date>
        <news:title>China International Consumer Products Expo 2026 Underway in Haikou with Over 3,400 Brands</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bc142f01-b581-4720-8cb2-936c607a9600/small/hc-png.png</image:loc>
        </image:image>
    </url>
</urlset>
